
    
      This study is an extension of protocol AAG-G-H-1220 wherein patients were randomized to
      either NOVOCART 3D or Microfracture treatment groups. This prospective single arm extension
      study is only open to participants of AAG-G-H-1220 who were randomized to Microfracture
      treatment and who failed Microfracture treatment.
    
  